The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study

Background and Aims: There is conflicting evidence regarding the association between proton pump inhibitors (PPI) and the risk of acquisition and severity of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Aim: To evaluate the association between PPI exposure and infection and devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafrir, Asher, Benson, Ariel A., Katz, Lior H., Hershcovici, Tiberiu, Bitan, Menachem, Paltiel, Ora, Calderon-Margalit, Ronit, Safadi, Rifaat, Shauly-Aharonov, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854493/
https://www.ncbi.nlm.nih.gov/pubmed/35185561
http://dx.doi.org/10.3389/fphar.2022.791074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854493/
https://www.ncbi.nlm.nih.gov/pubmed/35185561
http://dx.doi.org/10.3389/fphar.2022.791074

Ejemplares similares